{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:00:35Z","timestamp":1790791235729,"version":"4.1.0"},"reference-count":31,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Interact J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec sec-type=\"background\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Clostridioides difficile<\/jats:italic>\n                      infection (CDI) is the most common cause of health care\u2013associated infectious diarrhea; however, variability in laboratory testing results in uncertainty in diagnosis and clinical decision-making. Recurrent CDI (rCDI), defined as the return of infection following initial treatment, continues to present significant clinical challenges due to limited therapeutic options. Although health care providers are familiar with vancomycin as first-line therapy for CDI, many are less familiar with fecal microbiota transplantation (FMT), despite its recommendation in clinical guidelines for rCDI management. Consequently, primary care providers (PCPs) may experience uncertainty regarding diagnostic test interpretation, treatment selection, and referral for FMT, highlighting the need for practical clinical tools to support evidence-based management.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"objective\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study will support the standardization of care and improve patient treatment experiences in Alberta by identifying barriers and facilitators encountered by PCPs in managing CDI and rCDI, using these findings to codevelop a provincial rCDI clinical pathway.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This qualitative study investigated the codevelopment process of a provincial rCDI clinical pathway between the study team and intended end users. A draft pathway was developed by the study team comprising gastroenterology and infectious disease specialists, followed by an iterative end user\u2013centered design approach. PCP participants completed 2 rounds of 60\u2010 to 90-minute virtual, one-on-one, semistructured interviews incorporating scenario-based usability testing with standardized clinical cases. Using a think-aloud approach, participants evaluated the pathway\u2019s clarity, diagnostic decision-making, treatment recommendations, referral processes, and integration into clinical workflows. Feedback was analyzed using thematic analysis, informed iterative revisions were made to the pathway and accompanying user guide, and they were reevaluated in a second round of interviews.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Out of 30 invited PCPs, 3 (10%) participated in this study. During the first round of interviews, participants identified challenges interpreting PCR-positive vs toxin-positive test results, navigating the pathway layout, locating embedded hyperlinks, and understanding FMT referral processes. Iterative, feedback-driven revisions addressed these barriers by improving diagnostic guidance, simplifying navigation, increasing hyperlink visibility, and clarifying referral timing with a user guide. During the second round of interviews, all participants reported that modifications improved CDI test result interpretation, streamlined navigation, enhanced workflow integration, and increased confidence in applying the pathway to clinical scenarios. The final version of this pathway was well received for its clarity, readability, and clinical utility, and was viewed as a valuable educational resource for supporting evidence-based management of CDI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study demonstrated the feasibility and value of codeveloping a provincial clinical pathway with physician partners for managing CDI and rCDI. The resulting tool was clear, practical, and aligned with primary care workflows. This iterative, user-centered design was useful for developing clinically relevant decision support tools. Future research should evaluate the pathway\u2019s implementation and impact on physician practice, patient care, and clinical outcomes using quantitative and qualitative methods.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/93032","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T15:00:09Z","timestamp":1789570809000},"page":"e93032-e93032","source":"Crossref","is-referenced-by-count":0,"title":["Codeveloping a Clinical Pathway for Recurrent Clostridioides difficile Infection With Primary Care Providers: User-Centered Design Study"],"prefix":"10.2196","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8964-4676","authenticated-orcid":false,"given":"Ritika Kamlesh","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5843-322X","authenticated-orcid":false,"given":"Rose","family":"Franz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4287-891X","authenticated-orcid":false,"given":"Jordan","family":"Tate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3295-8896","authenticated-orcid":false,"given":"Jennifer","family":"Coppens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3005-4599","authenticated-orcid":false,"given":"Matthew","family":"Do Rego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8750-1271","authenticated-orcid":false,"given":"Christopher","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1579-3328","authenticated-orcid":false,"given":"Lauretta","family":"Ovadje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5588-2229","authenticated-orcid":false,"given":"Karen","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4133-9337","authenticated-orcid":false,"given":"Lynora","family":"Saxinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6096-0586","authenticated-orcid":false,"given":"Dina","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"issue":"1","key":"R1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08096-0","article-title":"The burden of CDI in the United States: a multifactorial challenge","volume":"23","author":"Feuerstadt","journal-title":"BMC Infect Dis"},{"issue":"2","key":"R2","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens13020118","article-title":"Clostridioides difficile infection: diagnosis and treatment challenges","volume":"13","author":"Markantonis","journal-title":"Pathogens"},{"issue":"3","key":"R3","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ajic.2023.08.008","article-title":"Health care\u2013associated Clostridioides difficile infection: learning the perspectives of health care workers to build successful strategies","volume":"52","author":"Lev","journal-title":"Am J Infect Control"},{"issue":"3","key":"R4","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1128\/JCM.02970-12","article-title":"Performance of Clostridium difficile toxin enzyme immunoassay and nucleic acid amplification tests stratified by patient disease severity","volume":"51","author":"Humphries","journal-title":"J Clin Microbiol"},{"issue":"7","key":"R5","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1093\/cid\/cir505","article-title":"Diagnostic accuracy of real-time polymerase chain reaction in detection of Clostridium difficile in the stool samples of patients with suspected Clostridium difficile infection: a meta-analysis","volume":"53","author":"Deshpande","journal-title":"Clin Infect Dis"},{"issue":"3","key":"R6","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1053\/j.gastro.2024.01.008","article-title":"AGA clinical practice guideline on fecal microbiota-based therapies for select gastrointestinal diseases","volume":"166","author":"Peery","journal-title":"Gastroenterology"},{"issue":"6","key":"R7","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.14309\/ajg.0000000000001278","article-title":"ACG clinical guidelines: prevention, diagnosis, and treatment of Clostridioides difficile infections","volume":"116","author":"Kelly","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"R8","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1093\/cid\/ciu128","article-title":"Cost-effectiveness of competing strategies for management of recurrent Clostridium difficile infection: a decision analysis","volume":"58","author":"Konijeti","journal-title":"Clin Infect Dis"},{"issue":"9","key":"R9","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1097\/MCG.0000000000000494","article-title":"Cost averted with timely fecal microbiota transplantation in the management of recurrent Clostridium difficile infection in Alberta, Canada","volume":"50","author":"Waye","journal-title":"J Clin Gastroenterol"},{"issue":"9","key":"R10","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1097\/MCG.0000000000000447","article-title":"A high rate of alternative diagnoses in patients referred for presumed Clostridium difficile infection","volume":"50","author":"Jackson","journal-title":"J Clin Gastroenterol"},{"issue":"11","key":"R11","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1097\/PEC.0000000000000861","article-title":"Implementation of a clinical pathway for chest pain in a pediatric emergency department","volume":"34","author":"Mohan","journal-title":"Pediatr Emerg Care"},{"issue":"4","key":"R12","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1007\/s11605-017-3653-1","article-title":"The effectiveness of a clinical pathway in liver surgery: a case-control study","volume":"22","author":"Ovaere","journal-title":"J Gastrointest Surg"},{"issue":"1","key":"R13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-062158","article-title":"Barriers and enablers to implementing clinical practice guidelines in primary care: an overview of systematic reviews","volume":"13","author":"Wang","journal-title":"BMJ Open"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1016\/j.injury.2022.01.047","article-title":"Clinical practice guidelines: the good, the bad, and the ugly","volume":"54 Suppl 3","author":"Guerra-Farfan","journal-title":"Injury"},{"key":"R15","unstructured":"Blondel-Hill E Fryters S . Bugs & Drugs. URL: https:\/\/www.bugsanddrugs.org\/ [Accessed 25-09-2026]"},{"issue":"5","key":"R16","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/apt.17309","article-title":"Faecal microbiota transplantation for recurrent C. difficile infections: challenges and improvement opportunities for clinical practice and healthcare systems","volume":"57","author":"Hocking","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"R17","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.jcjq.2019.10.002","article-title":"AHRQ EPC series on improving translation of evidence: use of a clinical pathway for C. difficile treatment to facilitate the translation of research findings into practice","volume":"45","author":"Flores","journal-title":"Jt Comm J Qual Patient Saf"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1177\/27550834231177503","article-title":"Co-created decision-making: from co-production to value co-creation in health care","volume":"7","author":"Amorim","journal-title":"J Med Access"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejon.2023.102353","article-title":"A self-directed co-creation process for developing a care pathway for patients on oral anticancer therapy: a qualitative process evaluation","volume":"65","author":"Kenis","journal-title":"Eur J Oncol Nurs"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejon.2022.102218","article-title":"A qualitative evaluation of the process of creating and implementing an interprofessional care pathway for patients treated with oral anticancer drugs","volume":"61","author":"Kinnaer","journal-title":"Eur J Oncol Nurs"},{"issue":"9","key":"R21","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1097\/PEC.0000000000000960","article-title":"Clinical pathway effectiveness: febrile young infant clinical pathway in a pediatric emergency department","volume":"33","author":"Murray","journal-title":"Pediatr Emerg Care"},{"issue":"7 Suppl","key":"R22","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.5694\/mja16.00112","article-title":"Embracing value co-creation in primary care services research: a framework for success","volume":"204","author":"Janamian","journal-title":"Med J Aust"},{"issue":"1","key":"R23","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-022-08079-y","article-title":"The use of co-production, co-design and co-creation to mobilise knowledge in the management of health conditions: a systematic review","volume":"22","author":"Grindell","journal-title":"BMC Health Serv Res"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.17161\/kjm.vol13.14762","article-title":"The effect of a clinical pathway on reducing the rate of healthcare-onset Clostridioides difficile","volume":"13","author":"Millard","journal-title":"Kans J Med"},{"issue":"2","key":"R25","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/ppul.23635","article-title":"Implementation of cystic fibrosis clinical pathways improved physician adherence to care guidelines","volume":"52","author":"Singh","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"R26","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2174\/1875036201811010140","article-title":"Enhanced teamwork communication model for electronic clinical pathways in healthcare","volume":"11","author":"Mater","journal-title":"Open Bioinform"},{"issue":"1","key":"R27","doi-asserted-by":"publisher","DOI":"10.13162\/hro-ors.v10i1.4680","article-title":"Implementing primary health care teams and integrated care in Alberta, Canada","volume":"10","author":"Montesanti","journal-title":"Health Reform Obs"},{"issue":"6","key":"R28","doi-asserted-by":"publisher","first-page":"400","DOI":"10.46747\/cfp.7206400","article-title":"Predictors of high-performing family medicine clinics: prospective cohort study in Alberta","volume":"72","author":"Kain","journal-title":"Can Fam Physician"},{"issue":"1","key":"R29","doi-asserted-by":"publisher","DOI":"10.1186\/s13690-024-01272-x","article-title":"Primary care involvement in clinical research - prerequisites, motivators, and barriers: results from a study series","volume":"82","author":"Wangler","journal-title":"Arch Public Health"},{"issue":"3","key":"R30","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1071\/HC25042","article-title":"Strategies for research capacity building by family physicians in primary care: a scoping review","volume":"18","author":"Gil Conde","journal-title":"J Prim Health Care"},{"key":"R31","doi-asserted-by":"publisher","DOI":"10.1177\/1609406919878341","article-title":"Conducting the pilot study: a neglected part of the research process? Methodological findings supporting the importance of piloting in qualitative research studies","volume":"18","author":"Malmqvist","journal-title":"Int J Qual Methods"}],"container-title":["Interactive Journal of Medical Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:53:13Z","timestamp":1790790793000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.i-jmr.org\/2026\/1\/e93032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":31,"URL":"https:\/\/doi.org\/10.2196\/93032","relation":{},"ISSN":["1929-073X"],"issn-type":[{"value":"1929-073X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"article-number":"v15i1e93032"}}